ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 1 filers reported holding ANTARES PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $426,000 | -99.0% | 104 | -99.1% | 0.00% | -100.0% |
| Q4 2021 | $41,018,000 | -69.0% | 11,490 | -68.4% | 0.01% | -68.8% |
| Q3 2021 | $132,437,000 | -11.9% | 36,385 | +6.2% | 0.03% | -5.9% |
| Q2 2021 | $150,337,000 | +2235.9% | 34,246 | +2023.1% | 0.03% | +1600.0% |
| Q4 2020 | $6,436,000 | +47.8% | 1,613 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $4,355,000 | -95.0% | 1,613 | -94.9% | 0.00% | -95.7% |
| Q2 2020 | $86,603,000 | +15.4% | 31,494 | -1.0% | 0.02% | +9.5% |
| Q1 2020 | $75,071,000 | – | 31,811 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 3,096,355 | $8,422,000 | 5.18% |
| JW Asset Management, LLC | 1,920,524 | $5,224,000 | 3.85% |
| Healthcare Value Capital, LLC | 250,000 | $680,000 | 2.64% |
| ARMISTICE CAPITAL, LLC | 10,300,000 | $28,016,000 | 2.12% |
| Broadfin Capital, LLC | 3,444,147 | $9,368,000 | 1.23% |
| PERKINS CAPITAL MANAGEMENT INC | 409,000 | $1,112,000 | 0.86% |
| MYCIO WEALTH PARTNERS, LLC | 1,896,500 | $5,158,000 | 0.48% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 1,012,600 | $2,754,000 | 0.22% |
| FALCON POINT CAPITAL, LLC | 130,200 | $354,000 | 0.21% |
| Brown Advisory Securities, LLC | 275,000 | $781,000 | 0.15% |